NVLN Logo.jpg
Novelion Therapeutics’ Subsidiary Launches JUXTAPID® (lomitapide) in Japan
December 16, 2016 08:35 ET | Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Dec. 16, 2016 (GLOBE NEWSWIRE) -- Novelion Therapeutics (NASDAQ:NVLN) (TSX:NVLN), today announced that subsidiary Aegerion Pharmaceuticals completed the first...
Amaranth Medical
Amaranth Medical Initiates Trial of Sub-100-Micron MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold
November 01, 2016 08:00 ET | Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , Nov. 01, 2016 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced the initiation of a clinical study of the Company’s latest-generation...
Renowned Cardiologist Dr. Rony Shimony Joins Biotricity Board of Advisors
November 01, 2016 08:00 ET | biotricity
REDWOOD CITY, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote...
U.S. News and World Report Names University of Colorado Hospital to Best Hospitals Honor Roll
August 02, 2016 00:51 ET | UCHealth
AURORA, Colo., Aug. 2, 2016 (GLOBE NEWSWIRE) -- For the first time, U.S. News and World Reporthas named University of Colorado Hospital (UCH) to the Best Hospitals Honor Roll, recognizing it as one of...
Amaranth Medical
Amaranth Medical Completes Enrollment in RENASCENT-II Study of 120-Micron APTITUDE™ Sirolimus-Eluting Bioresorbable Scaffold
June 06, 2016 08:00 ET | Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , June 06, 2016 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced that it completed enrollment in May 2016 in the RENASCENT-II study of its...
American Society of Echocardiography 27th Annual Scientific Sessions Feature Live Case Demonstrations, an Innovation Challenge Competition, and Cutting-Edge Research
May 31, 2016 15:14 ET | American Society of Echocardiography
MORRISVILLE, N.C., May 31, 2016 (GLOBE NEWSWIRE) -- The American Society of Echocardiography (ASE) will host its 27th Annual Scientific Sessions June 10-14, 2016 at the Washington State Convention...
Oncology and Cardiology Fair Market Value Compensation Rates Increase up to 36 Percent in 2016
April 13, 2016 09:30 ET | Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - April 13, 2016) - Trends in fair market value (FMV) compensation rates among surveyed Tier 3 oncology and cardiology specialists have shown an overall...
Admera Health Launches Molecular Test for Inherited Early Atherosclerosis Diagnosis and Risk
March 17, 2016 07:00 ET | Admera Health, LLC
SOUTH PLAINFIELD, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Admera Health (www.admerahealth.com), a commercial stage New Jersey based Precision Medicine and Digital Health company announced today the...
The Heart Failure Society of America Launches New App to Help People Living With Heart Failure, in Partnership With Self Care Catalysts
February 02, 2016 08:30 ET | Self Care Catalysts;Heart Failure Society of America
BETHESDA, MD--(Marketwired - February 02, 2016) - The Heart Failure Society of America, Inc. (HFSA) kicked off 2016 with the launch of a new app, Heart Failure Health Storylines, to support...
Akers Bio logo
Akers Biosciences' Flagship Test for Heparin-Induced Thrombocytopenia Granted Approval by Chinese Food and Drug Administration
November 04, 2015 07:00 ET | Akers Biosciences Inc.
THOROFARE, N.J., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a medical device company focused on reducing the cost of healthcare...